Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE 10MG TABLET Resolved 2021-10-22 2021-12-09 147818
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-09 2022-01-06 148999
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-11-29 2021-12-17 150147
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2021-11-29 2022-01-29 150181
FOQUEST 35MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-12-02 2021-12-23 150348
FOQUEST 70MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-12-08 2021-12-21 150760
FOQUEST 100MG CAPSULE (CONTROLLED RELEASE) Actual shortage 2021-12-22 2024-05-13 151791
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-12-22 2022-01-27 151794
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-01-11 2022-02-26 152465
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-01-11 2022-02-17 152470

Showing 71 to 80 of 197

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPHENIDATE 5MG TABLET Discontinued 2019-04-10 2019-04-11 81132
METHYLPHENIDATE 10MG TABLET Discontinued 2019-04-10 2019-04-11 81136
METHYLPHENIDATE 20MG TABLET Discontinued 2019-04-10 2019-04-11 81139
RITALIN 20MG 20MG TABLET Discontinued 2019-07-22 2019-08-01 89771
PMS-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118099
PMS-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118102
PMS-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118105
PMS-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118108
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449

Showing 1 to 10 of 11